Table 7 Multivariate conditional logistic regression analysis of survival predictors among the 89 Calcific Uremic Arteriolopathy cases
Parameter | HR (95% CI) | p-value |
|---|---|---|
Hemoglobin at diagnosis, per 1 g/dL increment | 0.42 (0.30–0.60) | < 0.001 |
Insulin therapy | 0.28 (0.12–0.65) | 0.003 |
Lower limbs localization | < 0.001 | |
Below knee VS none | 0.13 (0.01–1.23) | 0.20 |
Above knee VS none | 0.17 (0.01–2.49) | 0.72 |
Any localization VS none | 107.04 (16.1–713) | < 0.001 |
Upper limbs localization | < 0.001 | |
Below elbow VS none | 10.79 (2.34–49.7) | 0.002 |
Any localization VS none | 267.48 (23.3–3069) | < 0.001 |
Type of CUA | < 0.001 | |
Distal-type VS proximal-type | 0.04 (0.00–0.44) | 0.008 |
Proximal and distal type VS proximal type | 0.01 (0.00–0.13) | < 0.001 |
Parathyroidectomy | 29.53 (3.87–226) | 0.001 |
Sevelamer | 0.26 (0.10–0.66) | 0.005 |
Lanthanum carbonate | 0.04 (0.01–0.21) | < 0.001 |
Surgical debridement | 0.11 (0.04–0.28) | < 0.001 |
Antibiotherapy | 0.25 (0.08–0.73) | 0.01 |
Local evolution of skin lesions | < 0.001 | |
Partial improvement VS complete healing | 1.14 (0.22–5.77) | 0.88 |
Deterioration VS complete healing | 497.78 (79.5–3118) | < 0.001 |
No improvement VS complete healing | 112.48 (12.4–1023) | < 0.001 |